Loss of Smell and Taste in Patients With Suspected COVID-19: Analyses of Patients' Reports on Social Media
- PMID: 33788699
- PMCID: PMC8064705
- DOI: 10.2196/26459
Loss of Smell and Taste in Patients With Suspected COVID-19: Analyses of Patients' Reports on Social Media
Abstract
Background: The year 2020 was the year of the global COVID-19 pandemic. The severity of the situation has become so substantial that many or even most of the patients with mild to moderate symptoms had to self-isolate without specific medical treatments or even without being tested for COVID-19. Many patients joined internet membership groups to exchange information and support each other.
Objective: Our goal is to determine the benefits and limits of using social media to understand the symptoms of patients with suspected COVID-19 with mild to moderate symptoms and, in particular, their symptoms of anosmia (loss of the sense of smell) and ageusia (loss of the sense of taste). The voluntary reports on an internet website of a membership group will be the platform of the analyses.
Methods: Posts and comments of members of an internet group known as COVID-19 Smell and Taste Loss, founded on March 24, 2020, to support patients with suspected COVID-19 were collected and analyzed daily. Demographic data were collected using the software mechanism called Group Insights on the membership group website.
Results: Membership groups on social media have become rare sources of support for patients with suspected COVID-19 with mild to moderate symptoms. These groups provided mental support to their members and became resources for information on COVID-19 tests and medicines or supplements. However, the membership was voluntary, and often the members leave without notification. It is hard to be precise from the free voluntary reports. The number of women in the group (6995/9227, 75.38% as of October 12, 2020) was about three times more than men (2272/9227, 24.62% as of October 12, 2020), and the peak age of members was between 20-40 years in both men and women. Patients who were asymptomatic other than the senses comprised 14.93% (53/355) of the total patients. Recovery of the senses was higher in the patients who were asymptomatic besides having anosmia and ageusia. Most (112/123, 91.06%) patients experienced other symptoms first and then lost their senses, on average, 4.2 days later. Patients without other symptoms tended to recover earlier (P=.02). Patients with anosmia and ageusia occasionally reported distorted smell and taste (parosmia and dysgeusia) as well as experiencing or perceiving the smell and taste without the sources of the smell or taste (phantosmia and phantogeusia).
Conclusions: Our analysis of the social media database of suspected COVID-19 patients' voices demonstrated that, although accurate diagnosis of patients is not always obtained with social media-based analyses, it may be a useful tool to collect a large amount of data on symptoms and the clinical course of worldwide rapidly growing infectious diseases.
Keywords: COVID-19; ageusia; anosmia; asymptomatic; benefit; diagnosis; free reports on social media; limit; patient-reported; recovery of senses; senses; smell; social media; symptom; symptomatic; taste.
©Sachiko Koyama, Rumi Ueha, Kenji Kondo. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 22.04.2021.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures








Similar articles
-
Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia.Int J Mol Sci. 2021 Aug 18;22(16):8912. doi: 10.3390/ijms22168912. Int J Mol Sci. 2021. PMID: 34445619 Free PMC article. Review.
-
Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends.Expert Rev Anti Infect Ther. 2020 Nov;18(11):1165-1170. doi: 10.1080/14787210.2020.1792289. Epub 2020 Jul 16. Expert Rev Anti Infect Ther. 2020. PMID: 32673122 Free PMC article.
-
Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.J Korean Med Sci. 2020 May 11;35(18):e174. doi: 10.3346/jkms.2020.35.e174. J Korean Med Sci. 2020. PMID: 32383370 Free PMC article.
-
New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination.Laryngoscope. 2022 Feb;132(2):419-421. doi: 10.1002/lary.29964. Epub 2021 Nov 26. Laryngoscope. 2022. PMID: 34812498 Free PMC article.
-
Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review.Am J Otolaryngol. 2021 Mar-Apr;42(2):102889. doi: 10.1016/j.amjoto.2020.102889. Epub 2021 Jan 6. Am J Otolaryngol. 2021. PMID: 33445036 Free PMC article.
Cited by
-
A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss.Rhinology. 2022 Jun 1;60(3):207-217. doi: 10.4193/Rhin21.415. Rhinology. 2022. PMID: 35398877 Free PMC article.
-
Giving a Voice to Patients With Smell Disorders Associated With COVID-19: Cross-Sectional Longitudinal Analysis Using Natural Language Processing of Self-Reports.JMIR Public Health Surveill. 2024 May 10;10:e47064. doi: 10.2196/47064. JMIR Public Health Surveill. 2024. PMID: 38728069 Free PMC article.
-
Age-Related Differences in Experiences With Social Distancing at the Onset of the COVID-19 Pandemic: A Computational and Content Analytic Investigation of Natural Language From a Social Media Survey.JMIR Hum Factors. 2021 Jun 9;8(2):e26043. doi: 10.2196/26043. JMIR Hum Factors. 2021. PMID: 33914689 Free PMC article.
-
Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia.Int J Mol Sci. 2021 Aug 18;22(16):8912. doi: 10.3390/ijms22168912. Int J Mol Sci. 2021. PMID: 34445619 Free PMC article. Review.
-
Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature.Front Public Health. 2023 Apr 20;11:1141093. doi: 10.3389/fpubh.2023.1141093. eCollection 2023. Front Public Health. 2023. PMID: 37151596 Free PMC article.
References
-
- Coronavirus: symptoms. World Health Organization. [2021-04-09]. https://www.who.int/health-topics/coronavirus#tab=tab_3.
-
- Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19) Centers for Disease Control and Prevention. [2021-04-09]. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-manageme....
-
- Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020 Sep 01;173(5):362–367. doi: 10.7326/M20-3012. https://www.acpjournals.org/doi/abs/10.7326/M20-3012?url_ver=Z39.88-2003... - DOI - DOI - PMC - PubMed
-
- Poletti P, Tirani M, Cerada D, Trentini F, Guzzetta G, Sabatino G, Marziano V, Castrofino A, Grosso F, Del Castillo G, Piccarreta R, ATS Lombardy COVID-19 Task Force. Andreassi A, Melegaro A, Gramegna M, Ajelli M, Merler S. Probability of symptoms and critical disease after SARS-CoV-2 infection. arXiv. Preprint posted online on June 15, 2020.
-
- Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki S, Ishihara T, Iwata M, Morise Z, Doi Y. Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med. 2020 Aug 27;383(9):885–886. doi: 10.1056/NEJMc2013020. http://europepmc.org/abstract/MED/32530584 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical